EPISODE · May 31, 2024 · 23 MIN
Biologics in COPD: Why, when and who
from The APAPP Podcast · host APAPP
Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients. Send us Fan MailClaim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.comFollow us on:Instagram @pulmapps Twitter@pulmapp Facebook @association of pulmonary advance practice providers.
What this episode covers
Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients. Send us Fan Mail Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and ...
NOW PLAYING
Biologics in COPD: Why, when and who
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m